Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Jeffrey R. Bishop, Mani N. Pavuluri

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

Risperidone is a commonly used medication for the treatment of bipolar disorder and schizophrenia in children and adolescents. It has been studied as a monotherapy treatment in early onset schizophrenia and as both monotherapy and combination therapy for pediatric bipolar disorder. Studies to date indicate that risperidone is an effective treatment for positive and negative symptoms of schizophrenia and mania symptoms of bipolar disorder. In young patient populations, side effects such as weight gain, extrapyramidal side effects, and prolactin elevation require consideration when evaluating the risk benefit ratio for individual patients. Here we review published studies of risperidone for the treatment of bipolar disorder and schizophrenia in children and adolescents to provide practitioners with an overview of published data on the efficacy and safety of risperidone in these patient populations.

Original languageEnglish (US)
Pages (from-to)55-68
Number of pages14
JournalNeuropsychiatric Disease and Treatment
Volume4
Issue number1 A
StatePublished - Apr 7 2008

Keywords

  • Adolescents
  • Bipolar disorder
  • Children
  • Risperidone
  • Schizophrenia

Fingerprint Dive into the research topics of 'Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia'. Together they form a unique fingerprint.

Cite this